联合抗血小板药物在缺血性脑卒中二级预防中的应用

Dual antiplatelet therapy in secondary ischemic stroke prevention

联合抗血小板药物可有效降低缺血性脑卒中复发风险,但也在一定程度上增加了出血的风险。在临床实践中,使用联合抗血小板药物需要评估,权衡利弊,尤其应对特定的人群、卒中亚型、用药时间、药物种类及数量以及安全性方面进行全面评估,以发挥有效二级预防疗效。

Dual antiplatelet therapy is effective in secondary ischemic stroke prevention.However,increased risk of hemorrhage in some patients was noted.It is necessary to balance the benefit and the risk while combined antiplatelet treatment.Target patients,etiological classifications of stroke,duration of medication,types and amounts of antiplatelet drugs and safety are all important aspects needed to be evaluated.